Endpoints News – Biotech, drug, pharma and health news for …
WEBJudge keeps Amgen's $10.7B tax liability suit alive. A New York federal judge has denied Amgen’s motion to dismiss a class action lawsuit alleging the company ...
ESMO23 | Cancer breakthroughs and barriers in oncology R&D
WEBAfter a decade of patient breakthroughs leveraging technologies like immunotherapy, ADCs and targeted therapies, cancer R&D is staring down its next era. Our expert panel will look at how the R&D landscape has shifted, new attempts to go after cancer's “undruggable” targets and how the field is thinking about where the goalposts are in what ...
News – Endpoints News
WEBThe Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry. Yesterday.
Endpoints at #ASCO24
WEBJun 4, 2024 · Endpoints at #ASCO24. Tuesday, June 4, 2024. 11:00 AM - 1:40 PM. Each year, the oncology world looks to the ASCO meeting to make sense of the clinical cancer landscape. Data coming out of the meeting will signal pipeline strengths and weaknesses, and point to the next directions for cancer treatment. We’ll cover the …
Endpoints at #BIO23: The dawn of a new biotech era
WEBThe dawn of a new biotech era. The biotech industry’s annual trade conference is back in Boston. We assess where we are as an industry and break down the future trends in biopharma. Featuring conversations on dealmaking, pipeline trends, biotech funding, and more — plus a focus on what the mid-year outlook holds. Register to watch.
About Endpoints News – Endpoints News
WEBJohn D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 20 years. Aside from ...
Endpoints at #JPM22 - A look at what's to come in 2022
WEBEndpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
Endpoints at #JPM24 | Primed to unlock biopharma's next …
WEBThe Endpoints Hub will be open for coworking & networking — power up your devices, check email and grab coffee and a bite between session. On Tuesday, you’ll go to biotech downturn survival school, hear about the data private investors expect to see in a tricky capital market and find out the future plans for pharma from top execs in the ...
Endpoints at #ASCO23 • June 5, 2023
WEBEndpoints at #ASCO23 • June 5, 2023. ASCO never fails to make its mark as the oncology conference to watch, no matter which way the data are. What pipelines are going to swell — or fade — as the readouts surface? Is a reshaping of the cancer landscape in the cards this year or will slow and steady win the race? Join Endpoints News’ ASCO ...
The most ambitious biotechs swinging for the fences in 2023
WEBWe’re back with another look at eleven of the most promising biotechs in the global industry. You can expect to see some great science, outstanding leadership and backers that are prepared to go the distance in one of the riskiest endeavors on the planet.